Leading Life Sciences AI Platform enables strategic
decision-making and targeted communication with real-time analytics
on KOL/HCP product perception in Spring 2024 Release
WASHINGTON, April 25,
2024 /PRNewswire-PRWeb/ -- Sorcero, the leading
provider of advanced AI solutions purpose-built for life sciences,
today announced the release of Scientific Sentiment, enabling Life
Sciences teams, for the first time, to quantify product perception
across KOLs and the market to more accurately measure trends,
identify evidence gaps, and quantify the ROI of outreach efforts.
By leveraging the most advanced medically-tuned large language
models (LLM) and combining them with Sorcero's innovative
Intelligent Medical Themes™(IMT), Scientific Sentiment accelerates
and unlocks a deeper understanding of efficacy and safety
information. Armed with these sentiment insights, Medical Affairs
teams can now confidently prioritize the next best actions to drive
product adoption and better serve patient needs.
Sorcero Scientific Sentiment empowers
Medical Affairs teams to make data-driven decisions faster by
providing access to relevant data and generating quantitative
metrics that inform strategic planning.
Traditionally, sentiment analysis has burdened medical affairs
teams by requiring them to manually label KOL/HCP interactions.
Given the increasingly large volumes of data that medical affairs
must analyze, this time-consuming process limits scalability and
forces teams to rely on outdated sentiment insights. Furthermore,
manual sentiment analysis is inherently subjective, which can
introduce unintended bias. While recent off-the-shelf sentiment
solutions have attempted to solve this problem, these AI tools lack
scientific understanding and struggle with ambiguity and an
over-reliance on rigid data labels. Sorcero's Scientific Sentiment
revolutionizes sentiment analysis by leveraging advanced large
language models and AI capabilities that understand scientific
context and can seamlessly process large datasets.
Sorcero Scientific Sentiment uses the platform's patented IMT to
automatically detect KOL/HCP sentiment on efficacy and safety
topics found in vast quantities of structured and unstructured
data. Medical topics are particularly difficult for traditional
Natural Language Processing (NLP) methods to correctly categorize
into themes. IMT uses Sorcero AI's medically-tuned LLMs and
ontologies to automatically identify complex medical themes, going
beyond concept tagging and identifying content with safety,
efficacy, or access concerns on specific products. The combination
of these AI-driven features allows for more comprehensive analysis
that gives medical affairs teams a deep understanding of safety and
efficacy sentiment gathered across multiple sources in real-time.
Teams can now:
- Quantify how KOLs and HCPs feel about safety and efficacy of
their product
- Measure the trends and changes in sentiment over time
- Measure impact of KOL/HCP engagement activities
- Segment and plan engagement with KOLs/HCPs based on Scientific
Sentiment
- Provide better support to adjacent teams such as MSLs and sales
reps on their field engagements
"This new functionality provides teams with a systematic
approach to measuring medical affairs functions that is more
practical, structured, and complete," commented Richard Graves, Co-founder and CCO, Sorcero.
"With a more comprehensive view of opinion than ever before,
Sorcero's Scientific Sentiment helps give customers a better sense
of how their KOLs feel about specific topics, and how these
sentiments change over time."
Sorcero is empowering Medical Affairs teams to make data-driven
decisions faster by providing access to relevant data and
generating quantitative metrics that inform strategic planning.
Sorcero Scientific Sentiment can also be used as a key performance
indicator (KPI) to measure the impact of engagement strategies and
guide future initiatives.
About Sorcero
Sorcero's medical AI platform transforms life sciences
decision-making, accelerating patient access to life-saving
treatments. By harnessing insights from global medical data, we
empower industry leaders to deliver breakthrough therapies. Founded
in 2018 by pioneers in AI, public health, and personalized content,
Sorcero is a Certified B Corp headquartered in Washington, DC. Our innovation has been
recognized by over a dozen awards, including Fast Company's Most
Innovative Companies of 2024, and six foundational medical AI
patents. Learn more at: http://www.Sorcero.com.
Media Contact
Christine Myers, Sorcero, +1 202
571 4889, cmyers@sorcero.com, www.sorcero.com
Twitter
View original
content:https://www.prweb.com/releases/sorcero-announces-new-scientific-sentiment-to-revolutionize-pharma-engagement-strategies-302127718.html
SOURCE Sorcero